Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

NanoPacific Holdings licenses nanoparticle techn from UCLA
January 2010
SHARING OPTIONS:

LOS ANGELES—NanoPacific Holdings Inc. (NPH) announced in December the acquisition of an exclusive license from University of California at Los Angeles (UCLA) for a suite of supramolecular nanoparticle technologies for molecular diagnostics and therapeutics. The agreement gives NPH access to a system composed of a ternary mixture of modular components that self-assemble into supramolecular nanoparticles. The technology enables the synthesis of new-generation nanoparticles with a high degree of size and morphological control, as well as tunable surface charge and chemistry. These properties enable the production of biodegradable nanoparticles that display improved physiological stability, longer blood retention times, low acute toxicity and low immunogenicity. According to NPH, the technology has profound implications for drug delivery, gene transfection centering on siRNA and companion diagnostics.

 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.